UK Approval Pending: Exciting New Weight Loss Pen Drug Awaits Regulatory Approval
By Maggie Fick and Ludwig Burger LONDON (Reuters) – Eli Lilly revealed on Thursday that it has not received the green light in Britain for the injection pen designed for its Mounjaro drug, which is intended for treating obesity and diabetes. This adds a layer of uncertainty to the timing of the product’s debut in …